PC
SAGE

Polar Capital’s Sage Therapeutics SAGE Stock Holding History

Polar Capital’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-22,500
Closed -$3.16M – 307
2019
Q3 		$3.16M Sell
22,500
-52,500
-70% -$8.78M 0.03% 244
2019
Q2 		$13.7M Sell
75,000
-50,000
-40% -$8.53M 0.12% 169
2019
Q1 		$19.9M Buy
125,000
+95,000
+317% +$13.8M 0.18% 148
2018
Q4 		$2.87M Sell
30,000
-5,000
-14% -$572K 0.03% 227
2018
Q3 		$4.94M Sell
35,000
-40,000
-53% -$6.17M 0.04% 217
2018
Q2 		$11.7K Buy
+75,000
New +$11.8M 0.07% 185
2016
Q2 		– Sell
-160,000
Closed -$5.13M – 271
2016
Q1 		$5.13M Buy
+160,000
New +$5.63M 0.1% 173
2015
Q3 		– Sell
-8,685
Closed -$634K – 284
2015
Q2 		$634K Buy
+8,685
New +$558K 0.01% 263

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return